Haloperidol Oral Tablet 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Haloperidol: Oral tablet (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6722.JPG
Haloperidol 0.5mg Tab
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 351 

What is this Medicine?

HALOPERIDOL (ha loe PER i dole) is used to treat schizophrenia. This medicine is also used to control tics and vocal outbursts in patients with Tourette's syndrome and treat behavioral problems in children with severe conduct disorders. It should only be used in these children if other medicines have not worked.

CVS Pharmacy Patient Statistics for Haloperidol: Oral tablet(0.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Haloperidol 0.5mg Tablet

NDC: 003780351
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Protect from light
Store at controlled room temperature (between 68 and 77 degrees F)
Haloperidol 0.5mg Tablet
Drug Image file DrugItem_6722.JPG
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 351 
Shape: round
Color: orange
Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Haloperidol

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.